Terms: = Pancreatic cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Treatment
23 results:
1. Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery.
Geng T; Leung E; Chamley LW; Wu Z
Biomater Adv; 2023 Jun; 149():213388. PubMed ID: 37003022
[TBL] [Abstract] [Full Text] [Related]
2. Predicting the chemosensitivity of pancreatic cancer cells as a personalized therapy.
Rudno-Rudzińska J; Michel O; Płochocki M; Kulbacka J
Adv Clin Exp Med; 2022 Sep; 31(9):1049-1053. PubMed ID: 36135813
[TBL] [Abstract] [Full Text] [Related]
3. The Therapeutic Effect of
Meng F; Lin Y; Hu L; Feng W; Su P; Wu L
J Healthc Eng; 2022; 2022():7282453. PubMed ID: 35463673
[No Abstract] [Full Text] [Related]
4. Bifacial PNAs Destabilize MALAT1 by 3' A-Tail Displacement from the U-Rich Internal Loop.
Miao S; Bhunia D; Devari S; Liang Y; Munyaradzi O; Rundell S; Bong D
ACS Chem Biol; 2021 Aug; 16(8):1600-1609. PubMed ID: 34382766
[TBL] [Abstract] [Full Text] [Related]
5. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
[TBL] [Abstract] [Full Text] [Related]
6. pancreatic cancer, treatment options, and GI-4000.
Hartley ML; Bade NA; Prins PA; Ampie L; Marshall JL
Hum Vaccin Immunother; 2015; 11(4):931-7. PubMed ID: 25933185
[TBL] [Abstract] [Full Text] [Related]
7. pancreatic cancer, treatment options, and GI-4000.
Hartley ML; Bade NA; Prins PA; Ampie L; Marshall JL
Hum Vaccin Immunother; 2014; 10(11):3347-53. PubMed ID: 25585100
[TBL] [Abstract] [Full Text] [Related]
8. Oxaliplatin and ototoxicity: is it really safe for hearing?
Yüce S; Seker MM; Koç S; Uysal IO; Kaçan T; Doğan M; Doğan M; Babacan NA; Kiliçkap S
Turk J Med Sci; 2014; 44(4):586-9. PubMed ID: 25551926
[TBL] [Abstract] [Full Text] [Related]
9. Antitumor effects of baculovirus-infected dendritic cells against human pancreatic carcinoma.
Fujihira A; Suzuki T; Chang MO; Moriyama T; Kitajima M; Takaku H
Gene Ther; 2014 Sep; 21(9):849-54. PubMed ID: 25009006
[TBL] [Abstract] [Full Text] [Related]
10. Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis.
Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
Curr Med Chem; 2013; 20(38):4888-923. PubMed ID: 24059235
[TBL] [Abstract] [Full Text] [Related]
11. Gemcitabine in patients with intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas.
Otsuka T; Morizane C; Nara S; Ueno H; Kondo S; Shimada K; Kosuge T; Ikeda M; Hiraoka N; Okusaka T
Pancreas; 2013 Jul; 42(5):889-92. PubMed ID: 23695798
[TBL] [Abstract] [Full Text] [Related]
12. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer.
Imrie CW; Connett G; Hall RI; Charnley RM
Aliment Pharmacol Ther; 2010 Nov; 32 Suppl 1():1-25. PubMed ID: 21054452
[TBL] [Abstract] [Full Text] [Related]
13. Multi-centric pancreatic cancer without PanIN lesion.
Naito Y; Eriguchi N; Kume T; Naito M; Nishimura M; Ohdo M; Itai N; Hayashida S; Naito H; Arikawa S; Ureshino H; Yasumoto M; Kusano H; Yano H
J Hepatobiliary Pancreat Surg; 2009; 16(5):699-703. PubMed ID: 19333539
[TBL] [Abstract] [Full Text] [Related]
14. Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.
Pipas JM; Barth RJ; Zaki B; Tsapakos MJ; Suriawinata AA; Bettmann MA; Cates JM; Ripple GH; Sutton JE; Gordon SR; McDonnell CE; Perez RP; Redfield N; Meyer LP; Marshall JF; Cole BF; Colacchio TA
Ann Surg Oncol; 2005 Dec; 12(12):995-1004. PubMed ID: 16252135
[TBL] [Abstract] [Full Text] [Related]
15. Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis.
Jinfeng M; Kimura W; Hirai I; Sakurai F; Moriya T; Mizutani M
Int J Gastrointest Cancer; 2003; 34(1):9-18. PubMed ID: 15235131
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreas.
Nio Y; Omori H; Toga T; Hashimoto K; Itakura M; Koike M; Yano S; Higami T
Anticancer Drugs; 2003 Apr; 14(4):313-9. PubMed ID: 12679736
[TBL] [Abstract] [Full Text] [Related]
17. pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract] [Full Text] [Related]
18. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer.
Roldan GE; Gunderson LL; Nagorney DM; Martin JK; Ilstrup DM; Holbrook MA; Kvols LK; McIlrath DC
Cancer; 1988 Mar; 61(6):1110-6. PubMed ID: 3342371
[TBL] [Abstract] [Full Text] [Related]
19. Curative surgery for adenocarcinoma of the pancreas/ampulla of Vater: the role of adjuvant pre or postoperative radiation therapy.
Kopelson G
Int J Radiat Oncol Biol Phys; 1983 Jun; 9(6):911-5. PubMed ID: 6408038
[TBL] [Abstract] [Full Text] [Related]
20. [Intraoperative radiotherapy of stomach cancer].
Satomura K; Inamoto S; Honda K; Takahashi M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2089-96. PubMed ID: 7184389
[TBL] [Abstract] [Full Text] [Related]
[Next]
